Samuel H. Myers

N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture

Jason T. Weiss, Craig Fraser, Belén Rubio‐Ruíz et al. · Frontiers in Chemistry · 2014 · 30 citations · Full text

Cancer Cell Culture, Palladium-mediated Dealkylation, N-alkynyl Derivatives +16

Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening

Samuel H. Myers, Carolin Temps, Douglas R. Houston et al. · Journal of Medicinal Chemistry · 2018 · 21 citations · Full text

Drug Target, Axl Kinase, Chemoprevention Strategy +20

An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer

Samuel H. Myers, Laura Poppi, Francesco Rinaldi et al. · European Journal of Medicinal Chemistry · 2023 · 17 citations · Full text

Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway

Teresa Valero, Daniel J. Baillache, Craig Fraser et al. · Bioorganic & Medicinal Chemistry · 2019 · 16 citations · Full text

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria

Olga Pustotina, Samuel H. Myers, Vittorio Unfer et al. · Gynecologic and Obstetric Investigation · 2024 · 11 citations · Full text